SCHEMBL565041

SCHEMBL565041

COc1ccccc1CN(C)CC(C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.55
ALDH1A1 P00352 1/20 0.41
PTGES O14684 1/20 0.38
TACR1 P25103 1/20 0.38
HTR7 P34969 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
PDE7B Q9NP56 1/20 0.34
TSHR P16473 1/20 0.34
LPAR1 Q92633 1/20 0.34
LPAR5 Q9H1C0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565125 0.89 PROKR2 (0.57) PROKR2ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL565624 0.87 PROKR2 (0.56) PROKR2ALDH1A1MEN1KMT2AHPGD
SCHEMBL565781 0.87 PROKR2 (0.69) PROKR2ALDH1A1PTGESTACR1MEN1
SCHEMBL564884 0.87 PROKR2 (0.69) PROKR2ALDH1A1PTGESTACR1MEN1
SCHEMBL565042 0.86 PROKR2 (0.61) PROKR2ALDH1A1PTGESTACR1MEN1
SCHEMBL565850 0.83 PROKR2 (0.58) PROKR2
SCHEMBL565687 0.83 PROKR2 (0.61) PROKR2TACR1BCHEMEN1KMT2A
SCHEMBL10107144 0.82 PROKR2 (0.59) PROKR2ALDH1A1PTGESTACR1HPGD
SCHEMBL565505 0.82 PROKR2 (0.59) PROKR2ALDH1A1PTGESTACR1HPGD
SCHEMBL10119945 0.79 PROKR2 (0.70) PROKR2ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885ALDH1A1 4725/4885PTGES 1493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.